HighTower Advisors LLC Grows Stake in SPDR S&P Biotech ETF $XBI

HighTower Advisors LLC lifted its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 10.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 90,861 shares of the exchange traded fund’s stock after acquiring an additional 8,780 shares during the quarter. HighTower Advisors LLC owned 0.14% of SPDR S&P Biotech ETF worth $14,379,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Wealth Management Partners LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 1st quarter valued at approximately $547,000. Keystone Investors PTE Ltd. acquired a new position in SPDR S&P Biotech ETF during the fourth quarter worth $12,022,000. Jessup Wealth Management Inc purchased a new position in SPDR S&P Biotech ETF during the fourth quarter valued at $1,053,000. Lalia Capital LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at about $12,193,000. Finally, Rockefeller Capital Management L.P. increased its stake in shares of SPDR S&P Biotech ETF by 44.4% during the fourth quarter. Rockefeller Capital Management L.P. now owns 236,057 shares of the exchange traded fund’s stock worth $28,782,000 after purchasing an additional 72,636 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI stock opened at $159.38 on Thursday. The stock’s fifty day moving average is $158.42 and its two-hundred day moving average is $141.39. The firm has a market capitalization of $10.41 billion, a P/E ratio of 11.47 and a beta of 0.84. SPDR S&P Biotech ETF has a fifty-two week low of $92.64 and a fifty-two week high of $169.89.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.